Clinical Trials on Advanced Soft Tissue Sarcoma in Japan
Total 120 results
-
Novartis PharmaceuticalsCompleted3rd Line GISTFrance, United Kingdom, Belgium, Canada, Spain, Netherlands, Japan, United States
-
AmgenRecruitingAdvanced Solid TumorsTaiwan, Australia, United States, Japan, Korea, Republic of, Poland
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
Merck Sharp & Dohme LLCCompletedSkin Diseases, Infectious | Bacteremia | Soft Tissue InfectionsJapan
-
Kyowa Kirin Co., Ltd.CompletedTumor-Induced Osteomalacia or Epidermal Nevus SyndromeJapan, Korea, Republic of
-
Novartis PharmaceuticalsActive, not recruiting
-
BayerCompletedLeiomyomaBelgium, United States, Switzerland, Germany, Spain, Japan, Canada, Finland, Hungary, Bulgaria, Czechia, Norway, Sweden
-
PfizerCompleted
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate Cancer, Advanced Breast CancerJapan
-
AstraZenecaCompletedAdvanced or Metastatic Breast Cancer | ER+ve Advanced or Metastatic Breast CancerCanada, France, Korea, Republic of, Czechia, Peru, United Kingdom, Spain, Japan, Mexico, Singapore, Bulgaria
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersTaiwan, Hong Kong, Japan
-
BayerCompletedSkin Diseases, InfectiousJapan
-
AbbVieActive, not recruitingAdvanced Solid Tumors CancerUnited States, Australia, Canada, France, Japan, Korea, Republic of, Spain
-
PfizerRecruitingBreast Neoplasms | Prostate Cancer | Adenocarcinoma of Lung | Solid Tumors | Liposarcoma | CRCChina, United States, United Kingdom, Mexico, Czechia, Japan, Slovakia, Argentina
-
BayerTerminatedUterine Fibroids and Heavy Menstrual BleedingJapan
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive, HER2-negative, Advanced Breast CancerJapan, Hong Kong, Singapore
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
BayerActive, not recruitingUterine FibroidsUnited States, China, Thailand, Japan, Turkey, Czechia, Finland, Hong Kong, Mexico, Norway, Poland, Russian Federation, South Africa
-
University of CincinnatiNational Center for Research Resources (NCRR); Office of Rare Diseases (ORD); FDA Office of Orphan Products DevelopmentCompletedLymphangioleiomyomatosisUnited States, Canada, Japan
-
AbbVieCompletedAdvanced Parkinson's DiseaseJapan, Korea, Republic of, Taiwan
-
BayerTerminatedUterine FibroidsUnited States, Russian Federation, Japan, Czechia, Ukraine
-
Genzyme, a Sanofi CompanyCompletedUnresectable Locally Advanced or Metastatic, Medullary Thyroid CarcinomaJapan
-
BayerRecruitingAdvanced Solid TumorsUnited States, United Kingdom, Korea, Republic of, Japan, Spain, Belgium, China
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerJapan
-
AbbVieActive, not recruitingAdvanced Solid TumorsUnited States, Australia, Canada, Israel, Japan, Korea, Republic of, Netherlands, Puerto Rico, Spain, Taiwan
-
BayerCompletedGastrointestinal Stromal TumorsBelgium, Canada, Spain, United States, Finland, Korea, Republic of, Austria, United Kingdom, Italy, China, Israel, France, Poland, Germany, Netherlands, Japan, Singapore
-
Translational Research Center for Medical Innovation...Niigata University Medical & Dental HospitalCompletedMetastatic Cancer | Gastrointestinal Stromal TumorJapan
-
Translational Research Center for Medical Innovation...Niigata University Medical & Dental HospitalCompletedMetastatic Cancer | Gastrointestinal Stromal TumorJapan
-
Novartis PharmaceuticalsCompletedNeuroendocrine Tumors | Advanced NET of GI Origin | Advanced NET of Lung OriginUnited States, Colombia, Italy, Taiwan, United Kingdom, Belgium, Czechia, Germany, Japan, Saudi Arabia, Canada, Netherlands, Spain, Korea, Republic of, Lebanon, Austria, China, Greece, South Africa, Thailand, Hungary, Turkey, Poland, ... and more
-
Volastra Therapeutics, Inc.AmgenCompletedAdvanced Solid TumorsUnited States, Canada, Italy, Australia, Japan, Belgium, Spain
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
Kyowa Kirin Co., Ltd.CompletedAdvanced or Recurrent Breast CancerJapan
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Korea, Republic of, Taiwan, Canada, Italy, Japan, Portugal, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingLocally Advanced or Metastatic Malignant Solid TumorsUnited States, Japan, Canada
-
Novartis PharmaceuticalsCompletedGastrointestinal Stromal Tumor (GIST)China, South Africa, United States, France, Italy, United Kingdom, Germany, Taiwan, Turkey, Canada, Egypt, Singapore, Argentina, Austria, Poland, Russian Federation, Spain, Sweden, Thailand, Korea, Republic of, Bulgaria, Denmark, Japan and more
-
Clementia Pharmaceuticals Inc.TerminatedExostoses, Multiple HereditaryUnited States, Spain, Canada, Japan, Italy, Portugal, United Kingdom, Turkey, Australia, Belgium, France, Netherlands
-
Novartis PharmaceuticalsActive, not recruitingAdvanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,MelanomaTaiwan, United States, Netherlands, Spain, Korea, Republic of, Italy, Japan, Canada, Singapore
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Korea, Republic of, Japan
-
Gilead SciencesRecruitingStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (ASCENT-J02)Advanced Solid Tumor | Metastatic Urothelial Cancer | Metastatic Triple-Negative Breast Cancer | HR+/HER2- Metastatic Breast CancerJapan
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Breast CancerKorea, Republic of, Taiwan, Hong Kong, United States, Japan, Croatia, United Kingdom, Hungary, Australia, Canada, Serbia, Singapore, South Africa, Poland, Spain, Russian Federation, Romania, Austria, Belgium, Bulgaria, Czechia, Fr... and more
-
AbbVieRecruitingAdvanced Solid Tumors CancerUnited States, Australia, Israel, Japan, Korea, Republic of, Puerto Rico, Spain, Taiwan, Canada, France, Belgium
-
AbbVieCompletedAdvanced Solid Tumors CancerUnited States, France, Japan, Puerto Rico, Spain, Taiwan
-
AbbVieCompletedAdvanced Solid TumorsUnited States, Australia, Austria, Belgium, Canada, Finland, France, Japan, Spain, Taiwan
-
Novartis PharmaceuticalsCompletedAdvanced Neuroendocrine Tumors of Pancreatic OriginCanada, France, United Kingdom, Taiwan, Belgium, Spain, Netherlands, United States, Italy, Sweden, Switzerland, Thailand, Germany, Greece, Korea, Republic of, Japan, Brazil, Slovakia
-
AstraZenecaDaiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, TokyoActive, not recruitingAdvanced or Metastatic Breast CancerUnited States, Belgium, Canada, Denmark, France, Italy, Spain, Hungary, Poland, Taiwan, Russian Federation, Germany, Korea, Republic of, Brazil, Japan, Mexico, United Kingdom, China, Israel, Austria, Australia, Saudi Arabia, Netherl... and more
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerSpain, Denmark, United States, Korea, Republic of, Germany, Belgium, Vietnam, United Kingdom, France, Japan, Canada, China, India, Malaysia, Taiwan, Thailand, Australia, Turkey, Argentina, Brazil, Poland, Sweden, Italy
-
PfizerTerminatedAdvanced CancerUnited States, Canada, United Kingdom, Taiwan, Australia, France, Japan, Poland
-
PfizerRecruitingAdvanced or Metastatic Breast CancerUnited States, Taiwan, Canada, Japan, China, Korea, Republic of, Israel, Argentina, Mexico, Australia, Brazil, United Kingdom, India
-
PfizerArvinas Estrogen Receptor, Inc.RecruitingAdvanced Breast CancerChina, Japan, United States, Taiwan, Canada, Korea, Republic of, Spain, Bulgaria, Turkey, Finland, Italy, Czechia, India, Slovakia, South Africa, Germany, Australia, Brazil, Greece, Puerto Rico, Belgium, Argentina, Switzerland, Poland, ... and more